Surgery Partners posts narrower Q3 loss and lifts merger price to $25 per share
Surgery Partners reported a net loss of $21.1 million, or $0.16 per share, for Q3 2026 on revenue of $815.3 million, a slight improvement from the prior year. The company also announced that the pending cash merger with HealthSpan Partners has been revised to $25 per share, raising the total enterprise value to about $6 billion and targeting a closing in Q1 2027. The earnings beat the consensus EPS estimate by $0.04, supporting the stock’s modest post‑earnings rally.
Why it matters
The higher merger consideration increases the cash payout to shareholders, improving the deal’s economics. The earnings beat may sustain short‑term buying pressure as investors price in the upgraded cash offer.
Key facts
- 1Q3 2026 revenue was $815.3 million, 0.8% lower than the prior year. rttnews.com
- 2Net loss for the quarter was $21.1 million, or $0.16 per share. rttnews.com
- 3Same‑facility revenue grew 6% year over year. rttnews.com
- 4Adjusted EBITDA was $132.7 million. rttnews.com
- 5The merger price was increased to $25 per share in cash, valuing the transaction at approximately $6 billion. rttnews.com
- 6The merger is expected to close in the first quarter of 2027. rttnews.com
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.